Status: current, Defined. Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2615299012 | Extended release injectable suspension (product) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| 2617961013 | Extended release injectable suspension | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 2660547014 | Extended release injectable suspension (qualifier value) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 3633815017 | Prolonged-release suspension for injection | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3633816016 | Extended-release suspension for injection | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3633817013 | Prolonged-release suspension for injection (dose form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Extended-release suspension for injection | Is a | Conventional release suspension for injection | false | Inferred relationship | Some | ||
| Extended-release suspension for injection | Has dose form administration method | Inject | true | Inferred relationship | Some | ||
| Extended-release suspension for injection | Has dose form intended site | Parenteral | true | Inferred relationship | Some | ||
| Extended-release suspension for injection | Has basic dose form | Suspension | true | Inferred relationship | Some | ||
| Extended-release suspension for injection | Is a | Parenteral dose form | true | Inferred relationship | Some | ||
| Extended-release suspension for injection | Has dose form release characteristic | Prolonged-release | true | Inferred relationship | Some | ||
| Extended-release suspension for injection | Has dose form transformation | No transformation | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cabotegravir 200 mg/mL prolonged-release suspension for injection | Has manufactured dose form | True | Extended-release suspension for injection | Inferred relationship | Some | |
| Rilpivirine 300 mg/mL prolonged-release suspension for injection | Has manufactured dose form | True | Extended-release suspension for injection | Inferred relationship | Some | |
| Paliperidone (as paliperidone palmitate) 200 mg/mL prolonged-release suspension for injection | Has manufactured dose form | True | Extended-release suspension for injection | Inferred relationship | Some | |
| Estradiol cypionate 10 mg/mL and medroxyprogesterone acetate 50 mg/mL prolonged-release suspension for injection | Has manufactured dose form | True | Extended-release suspension for injection | Inferred relationship | Some |
Reference Sets
Qualifier value foundation reference set
FHIR